-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GfgjxbDUn2N5N8bFL0xBl5pUMzrOGpLe2IPZO8efeB+yFB+q7HomgOxJ6HHbWqm/ u1J7xvNyknWt40n3HZ20cQ== 0001209191-08-012829.txt : 20080225 0001209191-08-012829.hdr.sgml : 20080225 20080225142716 ACCESSION NUMBER: 0001209191-08-012829 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080221 FILED AS OF DATE: 20080225 DATE AS OF CHANGE: 20080225 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6455 NANCY RIDGE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584526600 MAIL ADDRESS: STREET 1: 6455 NANCY RIDGE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gillespie Deirdre CENTRAL INDEX KEY: 0001354737 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24274 FILM NUMBER: 08639086 BUSINESS ADDRESS: BUSINESS PHONE: 857-753-4093 MAIL ADDRESS: STREET 1: 416 MARLBOROUGH STREET STREET 2: APT. 707 CITY: BOSTON STATE: MA ZIP: 02115 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2008-02-21 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001354737 Gillespie Deirdre 6455 NANCY RIDGE DRIVE SAN DIEGO CA 92121 1 1 0 0 President & CEO Stock Options (right to buy) 2.42 2008-02-21 4 A 0 150000 0.00 A 2018-02-21 Common Stock 150000 150000 D The stock options vest and become exercisable monthly over the next four years. /s/ Gail A. Sloan Attorney-in-fact for Deirdre Y. Gillespie 2008-02-25 -----END PRIVACY-ENHANCED MESSAGE-----